Literature DB >> 1457324

Renal hypoplasia and postnatally acquired cortical loss in children with vesicoureteral reflux.

S A Hinchliffe1, Y F Chan, H Jones, N Chan, A Kreczy, D van Velzen.   

Abstract

We reviewed histologically 86 nephrectomy specimens from patients with vesicoureteral reflux (with or without ureterovesical obstruction) to investigate the relationship between coexisting hypoplasia and postnatally acquired cortical damage. Hypoplasia was assessed independently of the acquired cortical loss using medullary ray glomerular counting. Severe hypoplasia (glomerular number < 25% of normal) was detected in 47 of 86 patients. These patients underwent nephrectomy at a significantly younger age than those with minimal or no hypoplasia (P < 0.01). There was no significant relationship between the severity of hypoplasia and the presence or absence of obstruction. Severe acquired cortical loss was found in 68 of 86 patients. There was no significant association between the severity of cortical loss and the presence or absence of obstruction, age at nephrectomy or degree of coexisting hypoplasia. The findings suggest a strong association of hypoplasia and vesicoureteral reflux. Therefore, early postnatal presentation with minimal renal function need not necessarily reflect a failure of management but rather a pre-existing limitation of renal capacity. Furthermore, in a significant proportion of fetuses with ultrasonographic evidence of urinary tract abnormality, renal pathology may be present prior to the time at which in utero surgical intervention may be considered.

Entities:  

Mesh:

Year:  1992        PMID: 1457324     DOI: 10.1007/bf00874007

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  16 in total

1.  "Medullary ray glomerular counting" as a method of assessment of human nephrogenesis.

Authors:  S A Hinchliffe; P H Sargent; Y F Chan; D van Velzen; C V Howard; J L Hutton; D I Rushton
Journal:  Pathol Res Pract       Date:  1992-08       Impact factor: 3.250

2.  In utero treatment of urinary tract obstruction.

Authors:  M S Golbus; M R Harrison; R A Filly; P W Callen; M Katz
Journal:  Am J Obstet Gynecol       Date:  1982-02-15       Impact factor: 8.661

3.  Management of the fetus with a correctable congenital defect.

Authors:  M R Harrison; M S Golbus; R A Filly
Journal:  JAMA       Date:  1981-08-14       Impact factor: 56.272

4.  Fetal urinary tract obstruction: what is the role of surgical intervention in utero?

Authors:  R L Berkowitz; M G Glickman; G J Smith; N J Siegel; R M Weiss; M J Mahoney; J C Hobbins
Journal:  Am J Obstet Gynecol       Date:  1982-10-15       Impact factor: 8.661

5.  Human intrauterine renal growth expressed in absolute number of glomeruli assessed by the disector method and Cavalieri principle.

Authors:  S A Hinchliffe; P H Sargent; C V Howard; Y F Chan; D van Velzen
Journal:  Lab Invest       Date:  1991-06       Impact factor: 5.662

6.  Duplex kidneys: a correlation of renal dysplasia with position of the ureteral orifice.

Authors:  G G Mackie; F D Stephens
Journal:  J Urol       Date:  1975-08       Impact factor: 7.450

7.  Management of the fetus with a urinary tract malformation.

Authors:  M R Harrison; R A Filly; J T Parer; M J Faer; J B Jacobson; A A de Lorimier
Journal:  JAMA       Date:  1981-08-07       Impact factor: 56.272

8.  Prenatal diagnosis of urinary tract abnormalities by ultrasound.

Authors:  I Helin; P H Persson
Journal:  Pediatrics       Date:  1986-11       Impact factor: 7.124

9.  Paraureteral diverticula. Associated renal morphology and embryogenesis.

Authors:  S F Wickramasinghe; F D Stephens
Journal:  Invest Urol       Date:  1977-03

10.  The pathogenesis of reflux nephropathy.

Authors:  P G Ransley; R A Risdon
Journal:  Contrib Nephrol       Date:  1979       Impact factor: 1.580

View more
  8 in total

Review 1.  Vesicoureteric reflux and urinary tract infection in children.

Authors:  I Blumenthal
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

2.  A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13.

Authors:  Patricia L Weng; Simone Sanna-Cherchi; Terry Hensle; Ellen Shapiro; Alan Werzberger; Gianluca Caridi; Claudia Izzi; Anita Konka; Adam C Reese; Rong Cheng; Samuel Werzberger; Richard N Schlussel; Robert D Burk; Joseph H Lee; Roberto Ravazzolo; Francesco Scolari; Gian Marco Ghiggeri; Kenneth Glassberg; Ali G Gharavi
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

3.  Features of primary vesicoureteric reflux detected by investigation of foetal hydronephrosis.

Authors:  E A Oliveira; J S Diniz; J M Silva; E A Rabelo; A K Pontes; M F Souza
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

4.  Clinical course of prenatally detected primary vesicoureteral reflux.

Authors:  José Maria Penido Silva; Eduardo Araujo Oliveira; José Silvério Santos Diniz; Maria Cândida Ferrarez Bouzada; Renata Moura Vergara; Barbara Caldeira Souza
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

5.  Primary, nonsyndromic vesicoureteric reflux and its nephropathy is genetically heterogeneous, with a locus on chromosome 1.

Authors:  S A Feather; S Malcolm; A S Woolf; V Wright; D Blaydon; C J Reid; F A Flinter; W Proesmans; K Devriendt; J Carter; P Warwicker; T H Goodship; J A Goodship
Journal:  Am J Hum Genet       Date:  2000-03-17       Impact factor: 11.025

6.  Ultrasound findings of ureteral reflux in early infancy.

Authors:  M Hiraoka; C Hori; S Tsuchida; H Tsukahara; M Sudo
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

7.  Primary Vesico-Ureteral Reflux: Comparison of Factors between Infants and Children.

Authors:  Hyeon Chan Jang; Kyung Hun Lee; Jae Shin Park
Journal:  Korean J Urol       Date:  2011-03-18

Review 8.  Renal Hypoplasia, From Grossly Insufficient to Not Quite Enough: Consideration for Expanded Concepts Based Upon the Author's Perspective With Historical Review.

Authors:  Stephen M Bonsib
Journal:  Adv Anat Pathol       Date:  2020-09       Impact factor: 4.571

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.